Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SUP
1426
DELISTED
Superior Industries International
SUP
| $7.38M | 0.01% |
280,000
-32,600
| -10% | -$860K |
|
1427
First Financial Corp
THFF
$976M
| $7.38M | 0.01% |
139,719
+12,419
| +10% | +$555K |
|
1428
Interparfums
IPAR
$3.67B
| $7.37M | 0.01% |
225,090
-32,023
| -12% | -$1.06M |
|
1429
Old Second Bancorp
OSBC
$1.32B
| $7.36M | 0.01% |
666,300
+107,564
| +19% | +$975K |
|
1430
World Kinect Corp
WKC
$1.85B
| $7.35M | 0.01% |
160,100
+23,000
| +17% | +$1.03M |
|
1431
United Parks & Resorts
PRKS
$2.04B
| $7.34M | 0.01% |
+388,000
| New | +$6.36M |
|
|
AIQ
1432
DELISTED
Alliance Healthcare Services
AIQ
| $7.32M | 0.01% |
762,960
+35,957
| +5% | +$292K |
|
|
BWP
1433
DELISTED
Boardwalk Pipeline Partners
BWP
| $7.31M | 0.01% |
420,995
+344,595
| +451% | +$5.89M |
|
1434
TTEC Holdings
TTEC
$77.9M
| $7.3M | 0.01% |
239,300
-23,700
| -9% | -$681K |
|
|
HTLF
1435
DELISTED
Heartland Financial USA, Inc.
HTLF
| $7.3M | 0.01% |
152,000
+12,100
| +9% | +$502K |
|
1436
Packaging Corp of America
PKG
$22.8B
| $7.29M | 0.01% |
+86,000
| New | +$7.21M |
|
|
CUNB
1437
DELISTED
CU Bancorp
CUNB
| $7.29M | 0.01% |
203,500
+19,300
| +10% | +$526K |
|
|
BGC
1438
DELISTED
General Cable Corporation
BGC
| $7.25M | 0.01% |
380,800
-58,800
| -13% | -$991K |
|
1439
AXIS Capital
AXS
$7.38B
| $7.25M | 0.01% |
111,100
-554,000
| -83% | -$33.3M |
|
1440
Insteel Industries
IIIN
$631M
| $7.25M | 0.01% |
203,300
-18,500
| -8% | -$627K |
|
|
ACOR
1441
DELISTED
Acorda Therapeutics
ACOR
| $7.25M | 0.01% |
3,212
-590
| -16% | -$1.4M |
|
|
BLMT
1442
DELISTED
BSB Bancorp, Inc.
BLMT
| $7.24M | 0.01% |
250,211
+63,411
| +34% | +$1.65M |
|
1443
ScottsMiracle-Gro
SMG
$3.55B
| $7.24M | 0.01% |
75,737
-234,663
| -76% | -$21M |
|
|
ENOC
1444
DELISTED
EnerNOC, Inc.
ENOC
| $7.2M | 0.01% |
1,200,338
+200,138
| +20% | +$1.16M |
|
1445
Peapack-Gladstone Financial
PGC
$828M
| $7.19M | 0.01% |
232,920
-37,700
| -14% | -$971K |
|
1446
PDF Solutions
PDFS
$2.15B
| $7.19M | 0.01% |
318,900
-163,100
| -34% | -$3.41M |
|
|
XEC
1447
DELISTED
CIMAREX ENERGY CO
XEC
| $7.19M | 0.01% |
+52,898
| New | +$7.08M |
|
1448
Apple Hospitality REIT
APLE
$3.79B
| $7.17M | 0.01% |
358,700
+335,600
| +1,453% | +$6.24M |
|
1449
State Street Utilities Select Sector SPDR ETF
XLU
$23B
| $7.16M | 0.01% |
294,800
+252,400
| +595% | +$6.03M |
|
1450
Canadian National Railway
CNI
$76.7B
| $7.16M | 0.01% |
106,200
-41,800
| -28% | -$2.76M |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.